Suppression of glucose uptake by TMEM16A also generates secondary effects by enhancing gluconeogenesis and glucose metabolic disorder, thereby exacerbating insulin resistance, lipogenic events, inflammatory responses, and other NAFLD‐related events (Figure 7E). Here, ANO1 is linked to glucose metabolism disease.